Stock Comparison
ARGX vs CYTK
argenx NV ADR and Cytokinetics Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$55.44B
$11.16B
P/E (TTM)
39.4
—
Forward P/E
34.0
117.7
Price/Sales
11.7
105.5
Price/Book
7.5
60.3
EV/EBITDA
33.9
-15.8
Dividend Yield
—
—
Profitability
Net Margin
31.40%
0.00%
Operating Margin
30.00%
-949.00%
Return on Equity
20.20%
-572.00%
Return on Assets
8.86%
-31.50%
Growth (YoY)
Revenue Growth
62.60%
1126.00%
Earnings Growth
114.00%
0.00%
Price & Risk
Beta
-0.0
0.4
52-Week High
$934.62
$84.55
52-Week Low
$510.06
$32.66
Analyst Target
$1,041.14
$105.60
Compare ARGX and CYTK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.